There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

PubMed ID:: 24577788

DOI:: 10.1002/cncr.28622

ScienceOpen disciplines: Chemistry

Keywords: Humans,Immunotherapy,Melanoma,drug therapy,Protein Kinase Inhibitors,therapeutic use,Proto-Oncogene Proteins B-raf,antagonists & inhibitors

Data availability:

ScienceOpen disciplines: Chemistry

Keywords: Humans, Immunotherapy, Melanoma, drug therapy, Protein Kinase Inhibitors, therapeutic use, Proto-Oncogene Proteins B-raf, antagonists & inhibitors

Ipilimumab before BRAF inhibitor treatment may be more beneficial than vice versa for the majority of patients with advanced melanoma.

Read this article at

Related collections

A Sustainable Future

Author and article information

Journal

Comments

Comment on this article

Similar content 1,655

Cited by 11